concentrations before the study.
Main outcome measures-Serum concentrations of Lp(a) lipoprotein, total cholesterol, high density lipoprotein cholesterol, very low density lipoprotein cholesterol, low density lipoprotein cholesterol, triglycerides, and apolipoproteins A-I, A-II, and B.
Results-Median serum Lp(a) lipoprotein concentration was 10-0 mg/100 ml in the microalbuminuric group and 4-9 mg/100 ml in the control group (p=0-007). 17 (41%) of the microalbuminuric patients and five (14%) of the control patients had Lp(a) lipoprotein values above the upper quartile of a normal population. Median serum triglycerides concentrations in the microalbuminuric and control groups were 1 15 mmol/l and 0-88 mmolIl respectively (p=0.03). Median very low density lipoprotein cholesterol concentration was 0-52 mmol/l in the microalbuminuric group and 0 40 mmol/l in the control group (p=0-03). No significant differences in serum concentrations of total cholesterol, high density lipoprotein cholesterol, low density lipoprotein cholesterol, or apolipoproteins A-I, A-II, and B were found between the groups.
Conclusions-Serum concentrations of Lp(a) lipoprotein are twice as high in insulin dependent diabetic patients with microalbuminuria as in those without microalbuminuria. Increased concentrations of Lp(a) lipoprotein might partly explain the increased morbidity and mortality from cardiovascular disease observed among patients with diabetic nephropathy.
Introduction
Mortality is 40 times higher in insulin dependent diabetic patients with nephropathy than in those without this complication.' Much of the excess mortality is caused by cardiovascular disease.) Forty per cent of diabetic patients develop coronary heart disease within six years after manifesting nephropathy. 
Results
The median Lp(a) lipoprotein concentration in the microalbuminuric group (10 0 mg/l00 ml) was significantly higher than that in the control group (4-9mg/ 100 ml; p=0 007) (figure). The association between Lp(a) lipoprotein and cardiovascular disease is largely confined to patients with values above the upper quartile of the distribution of serum Lp(a) concentrations. '9 In healthy unrelated individuals examined in the same laboratory with the same technique, the upper quartile was 13 55 mg/100 ml (data not shown). In our study 17 In 1976 a study in Edinburgh and Stockholm gathered cross sectional data and explored reasons for the threefold excess of mortality from coronary heart disease in men aged 40 from Edinburgh.' The men from Edinburgh smoked more cigarettes, had slightly higher blood pressure, were more obese, had a greater insulin response to an oral glucose tolerance test, and had significantly lower adipose linoleic acid concentrations than men aged 40 from Stockholm. In addition they had higher fasting triglyceride and lower high density lipoprotein concentrations.' Serum total cholesterol and low density lipoprotein cholesterol concentrations did not differ between men from the two cities. This cross sectional study suggested, therefore, that raised cholesterol concentration may not be a major contributor to the high mortality from coronary heart disease in Scotland.
In assessing coronary risk factors it is also important to collect longitudinal data. Prospective studies have identified the increased risk of coronary disease associated with raised cholesterol concentration.67 The importance ofa low high density lipoprotein cholesterol concentration has been controversial.8'0 In Britain, the regional heart study initially reported the lack of an independent association between a low high density lipoprotein cholesterol and mortality from coronary heart disease," but subsequent reports suggest a different interpretation. '2 We examined whether total cholesterol, high density lipoprotein cholesterol, and low density lipoprotein cholesterol concentrations measured in the 1976 study proved to be significant factors in predicting those men
